Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis

The British Journal of Psychiatry : the Journal of Mental Science
J WijkstraW A Nolen

Abstract

The optimal pharmacological treatment of unipolar psychotic depression is uncertain. To compare the clinical effectiveness of pharmacological treatments for patients with unipolar psychotic depression. Systematic review and meta-analysis of randomised controlled trials. Ten trials were included in the review. We found no evidence that the combination of an antidepressant with an antipsychotic is more effective than an antidepressant alone. This combination was statistically more effective than an antipsychotic alone. Antidepressant monotherapy and adding an antipsychotic if the patient does not respond, or starting with the combination of an antidepressant and an antipsychotic, both appear to be appropriate options for patients with unipolar psychotic depression. However, clinically the balance between risks and benefits may suggest the first option should be preferred for many patients. Starting with an antipsychotic alone appears to be inadequate.

Associated Clinical Trials

Sep 12, 2008·PD Dr. Christine Norra, MD, PhD

References

Sep 1, 1990·The American Journal of Psychiatry·R F Anton, E A Burch
Jan 1, 1988·Journal of Affective Disorders·D G Spiker, D J Kupfer
Sep 23, 2000·Journal of Clinical Psychopharmacology·J A Wheeler VegaP J Tyson
Jul 3, 2004·Journal of Clinical Psychopharmacology·Anthony J RothschildGary D Tollefson
Jul 10, 2004·Psychopharmacology·Walter W van den BroekPeter Moleman
Oct 20, 2005·The Cochrane Database of Systematic Reviews·J WijkstraW A Nolen

❮ Previous
Next ❯

Citations

Oct 20, 2009·European Archives of Psychiatry and Clinical Neuroscience·Hans-Jürgen Möller, Wolfgang Maier
Oct 2, 2012·Journal of Affective Disorders·Anne Katrine K LeadholmSøren Dinesen Ostergaard
Jun 6, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gareth O MintonSarah E Gartside
Aug 13, 2008·The Australian and New Zealand Journal of Psychiatry·Chanaka Wijeratne, Perminder Sachdev
Apr 20, 2013·Schizophrenia Bulletin·Anthony J Rothschild
Oct 9, 2007·Current Opinion in Psychiatry·Jessica Broadway, Jacobo Mintzer
Mar 19, 2011·Psychiatry and Clinical Neurosciences·Yoshiteru TakekitaToshihiko Kinoshita
May 23, 2009·Journal of Psychopharmacology·J R Cardoso de AlmeidaG F Busatto
Jul 31, 2008·Drugs & Aging·John W Kasckow, Sidney Zisook
Dec 22, 2009·The Journal of Clinical Psychiatry·Brandon A Gaudiano, Mark Zimmerman
Oct 1, 2013·Aging Clinical and Experimental Research·Lucio GhioWerner Natta
Jul 29, 2008·Harvard Review of Psychiatry·Hesham M Hamoda, David N Osser
Mar 18, 2008·Journal of Clinical Psychopharmacology·Tom K BirkenhagerJan A Bruijn
Oct 27, 2007·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Jaap WijkstraWillem A Nolen
Apr 25, 2007·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael BauerUNKNOWN WFSBP Task Force on Unipolar Depressive Disorders
Feb 22, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Tsuyoshi MiyaokaJun Horiguchi
Aug 14, 2009·Journal of Affective Disorders·Raymond W LamUNKNOWN Canadian Network for Mood and Anxiety Treatments (CANMAT)
Apr 16, 2009·Acta Psychiatrica Scandinavica. Supplementum·G S MalhiUNKNOWN CADE Clinic, University of Sydney
Apr 4, 2008·Acta Psychiatrica Scandinavica·L F Gram, UNKNOWN Danish University Antidepressant Group (DUAG)
May 2, 2007·British Journal of Pharmacology·P K Gillman
Jun 27, 2013·Acta Psychiatrica Scandinavica·S D ØstergaardUNKNOWN STOP-PD Study Group
May 29, 2015·Acta Psychiatrica Scandinavica·S D ØstergaardB S Meyers
Jul 25, 2013·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Michael BauerUNKNOWN World Federation of Societies of Biological Psychiatry. Task Force on Unipolar Depressive Disorders
Nov 3, 2009·Journal of Affective Disorders·Jaap WijkstraWillem A Nolen
Nov 30, 2012·The International Journal of Neuropsychopharmacology·Covadonga M Díaz-CanejaCarmen Moreno
Dec 15, 2010·The Cochrane Database of Systematic Reviews·Katja KomossaStefan Leucht
Aug 13, 2013·Clinical Practice and Epidemiology in Mental Health : CP & EMH·D Stewart BellJill Siegelman
Oct 3, 2006·The British Journal of Psychiatry : the Journal of Mental Science·J J Vattakatuchery
Mar 17, 2020·International Review of Psychiatry·Gabriele SaniRoss J Baldessarini
Jun 1, 2009·Irish Journal of Psychological Medicine·Gary McDonald, Brian Hallahan
Oct 24, 2007·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Andrea CiprianiCorrado Barbui
Mar 11, 2021·Neuroscience and Biobehavioral Reviews·Joanne S CarpenterIan B Hickie
Jan 2, 2007·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
Nov 10, 2020·Psychotherapy and Psychosomatics·Steven L DubovskyVictoria Cranwell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here